| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 14.907 | 29.890 | 9.424 | 21.089 | 26.486 | 54.443 | 56.500 | 48.012 |
| Total Income - EUR | - | - | 18.913 | 29.890 | 13.550 | 33.100 | 26.786 | 55.094 | 56.679 | 48.319 |
| Total Expenses - EUR | - | - | 14.500 | 16.588 | 17.378 | 47.819 | 24.044 | 43.059 | 53.869 | 43.506 |
| Gross Profit/Loss - EUR | - | - | 4.413 | 13.302 | -3.828 | -14.718 | 2.741 | 12.035 | 2.810 | 4.813 |
| Net Profit/Loss - EUR | - | - | 3.621 | 12.406 | -4.209 | -15.542 | 1.947 | 10.713 | 2.245 | 4.333 |
| Employees | - | - | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Antobioferm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 23.751 | 22.438 | 25.015 | 49.423 | 48.562 | 100.551 | 104.394 | 103.430 |
| Current Assets | - | - | 233 | 2.098 | 65.440 | 10.841 | 7.178 | 3.708 | 2.537 | 6.501 |
| Inventories | - | - | 0 | 0 | 0 | 5.126 | 5.013 | 0 | 0 | 2.819 |
| Receivables | - | - | 46 | 0 | 29.022 | 4.328 | 1.023 | 1.959 | 0 | 1.017 |
| Cash | - | - | 188 | 2.098 | 36.418 | 1.386 | 1.143 | 1.749 | 2.537 | 2.666 |
| Shareholders Funds | - | - | 3.665 | 16.003 | 11.485 | -4.275 | -2.264 | 8.442 | 9.661 | 13.940 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 20.320 | 8.533 | 78.970 | 81.444 | 76.757 | 108.488 | 116.313 | 111.609 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9531 - 9531" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Antobioferm Srl